By group of action

Agents affecting the digestive system and metabolism

Name	Dosage form	ATC code
Alpha-tocopherol acetate (vitamin E) Alpha-tocopherol acetate (vitamin E) 50 mg/ml, 20 ml № 1 Oral oil solution Active ingredient Vitamin E-acetate Pharmacotherapeutic group Agents affecting the digestive system and metabolism More	50 mg/ml, 20 ml № 1	A11HA03
Alpha-tocopherol acetate (vitamin E) Alpha-tocopherol acetate (vitamin E) 100 mg/ml, 20 ml № 1 Oral oil solution Active ingredient Vitamin E-acetate Pharmacotherapeutic group Agents affecting the digestive system and metabolism More	100 mg/ml, 20 ml № 1	A11HA03
Alpha-tocopherol acetate (vitamin E) Alpha-tocopherol acetate (vitamin E) 300 mg/ml, 20 ml № 1 Oral oil solution Active ingredient Vitamin E-acetate Pharmacotherapeutic group Agents affecting the digestive system and metabolism More	300 mg/ml, 20 ml № 1	A11HA03
Aquavit-D3 Aquavit-D3 375 mcg/ml, 10 ml № 1 Oral solution Active ingredient Colecalciferol Pharmacotherapeutic group Agents affecting the digestive system and metabolism More	375 mcg/ml, 10 ml № 1	A11CC05
Ascorbic acid Ascorbic acid 25 mg № 100 Tablets Active ingredient Ascorbic acid Pharmacotherapeutic group Agents affecting the digestive system and metabolism More	25 mg № 100	A11GA01
Ascorbic acid Ascorbic acid 50 mg № 50 Dragee Active ingredient Ascorbic acid Pharmacotherapeutic group Agents affecting the digestive system and metabolism More	50 mg № 50	A11GA01
Ascorbic acid Ascorbic acid 50 mg/ml, 2 ml № 10, № 100 Solution for injections Active ingredient Ascorbic acid Pharmacotherapeutic group Agents affecting the digestive system and metabolism More	50 mg/ml, 2 ml № 10, № 100	A11GA01
Ascorbic acid Ascorbic acid 100 mg/ml, 2 ml № 10, № 100 Solution for injections Active ingredient Ascorbic acid Pharmacotherapeutic group Agents affecting the digestive system and metabolism More	100 mg/ml, 2 ml № 10, № 100	A11GA01
Ascorbic acid Ascorbic acid 25 mg №50 Tablets Active ingredient Ascorbic acid Pharmacotherapeutic group Agents affecting the digestive system and metabolism More	25 mg №50	A11GA01
Bisacodyl Bisacodyl 0,01 g № 10 Rectal suppositories Active ingredient Bisacodyl Pharmacotherapeutic group Agents affecting the digestive system and metabolism More	0,01 g № 10	A06AB02
Carbacid Pechaevskiy Carbacid Pechaevskiy № 20 Chewable tablets Active ingredient Comb drug Pharmacotherapeutic group Agents affecting the digestive system and metabolism More	№ 20	A02AX
Contracid Contracid 40 mg №1 Powder for solution for injections Active ingredient Pantoprazol Pharmacotherapeutic group Agents affecting the digestive system and metabolism More	40 mg №1	А02В С02
Dalmaxin Dalmaxin 0,2 g № 5, № 10 Suppositories Active ingredient Thiotriazolin Pharmacotherapeutic group Agents affecting the digestive system and metabolism More	0,2 g № 5, № 10	A05BA
Diosmectite Diosmectite 3,0 g №10 Powder for oral solution Active ingredient Diosmectite Pharmacotherapeutic group Agents affecting the digestive system and metabolism More	3,0 g №10	A07BC05
Ergocalciferol (vitamin D2) Ergocalciferol (vitamin D2) 0,125 %, 10 ml № 1 Oral oil solution Active ingredient Ergocalciferol Pharmacotherapeutic group Agents affecting the digestive system and metabolism More	0,125 %, 10 ml № 1	A11CC01
Glibenclamide Glibenclamide 5 mg № 30 Tablets Active ingredient Glibenclamide Pharmacotherapeutic group Agents affecting the digestive system and metabolism More	5 mg № 30	А10ВВ01
Heksavit Heksavit № 50 Dragee Active ingredient Comb drug Pharmacotherapeutic group Agents affecting the digestive system and metabolism More	№ 50	A11BA
Kreazim 10000 Kreazim 10000 № 20 Hard capsules Active ingredient Pancreatin Pharmacotherapeutic group Agents affecting the digestive system and metabolism More	№ 20	A09AA02
Kreazim 20000 Kreazim 20000 № 20 Hard capsules Active ingredient Pancreatin Pharmacotherapeutic group Agents affecting the digestive system and metabolism More	№ 20	A09AA02
Lekplex Lekplex 2 ml № 5 Active ingredient Pharmacotherapeutic group Agents affecting the digestive system and metabolism More	2 ml № 5	А11DВ
Leksadyl Leksadyl 10 mg № 10 Active ingredient Bisacodyl Pharmacotherapeutic group Agents affecting the digestive system and metabolism More	10 mg № 10	А06АВ02
Lektac Lektac 150 mg № 10, № 20, № 30 Active ingredient Pharmacotherapeutic group Agents affecting the digestive system and metabolism More	150 mg № 10, № 20, № 30	A02BA02
Loperamide Loperamide 0,002 g № 10, № 20 Tablets Active ingredient Loperamide hydrochloride Pharmacotherapeutic group Agents affecting the digestive system and metabolism More	0,002 g № 10, № 20	A07DA03
Methovitan Methovitan 20 hard capsules Hard capsules Active ingredient Comb drug Pharmacotherapeutic group Agents affecting the digestive system and metabolism More	20 hard capsules	А11АВ
Methyluracil Methyluracil 0,5 g, № 5 ,№ 10 Rectal suppositories Active ingredient 6-methyluracil Pharmacotherapeutic group Agents affecting the digestive system and metabolism More	0,5 g, № 5 ,№ 10	A14B
Nevrolek Nevrolek 2 ml № 5 Solution for injections Active ingredient Comb drug Pharmacotherapeutic group Agents affecting the digestive system and metabolism More	2 ml № 5	A11DB
No-H-Sha No-H-Sha 0,04 g № 10, № 30 Tablets Active ingredient Drotaverine hydrochloride Pharmacotherapeutic group Agents affecting the digestive system and metabolism More	0,04 g № 10, № 30	A03A D02
No-H-Sha No-H-Sha 20 mg/mg, 2 ml in ampoules № 5 Solution for injections Active ingredient Drotaverine hydrochloride Pharmacotherapeutic group Agents affecting the digestive system and metabolism More	20 mg/mg, 2 ml in ampoules № 5	A03AD02
No-H-Sha No-H-Sha 0,04 g № 10 Rectal suppositories Active ingredient Drotaverine hydrochloride Pharmacotherapeutic group Agents affecting the digestive system and metabolism More	0,04 g № 10	A03AD02
No-H-Sha forte No-H-Sha forte 0,08 g № 30 Tablets Active ingredient Drotaverine hydrochloride Pharmacotherapeutic group Agents affecting the digestive system and metabolism More	0,08 g № 30	A03AD02
Ondansetron Ondansetron 4 mg № 10 Film-coated tablets Active ingredient Ondansetron hydrochloride trihydrate Pharmacotherapeutic group Agents affecting the digestive system and metabolism More	4 mg № 10	A04AA01
Ondansetron Ondansetron 8 mg № 10 Film-coated tablets Active ingredient Ondansetron hydrochloride trihydrate Pharmacotherapeutic group Agents affecting the digestive system and metabolism More	8 mg № 10	A04AA01
Ondansetron Ondansetron 2 mg/ml 2 ml № 5 Solution for injections Active ingredient Ondansetron hydrochloride trihydrate Pharmacotherapeutic group Agents affecting the digestive system and metabolism More	2 mg/ml 2 ml № 5	A04AA01
Ondansetron Ondansetron 2 mg/ml 4 ml № 5 Solution for injections Active ingredient Ondansetron hydrochloride trihydrate Pharmacotherapeutic group Agents affecting the digestive system and metabolism More	2 mg/ml 4 ml № 5	A04AA01
Pancreatin 8000 Pancreatin 8000 № 20, №50 Enterosoluble tablets Active ingredient Pancreatin Pharmacotherapeutic group Agents affecting the digestive system and metabolism More	№ 20, №50	A09AA02
Pancreazim Pancreazim № 20, № 50 Enterosoluble tablets Active ingredient Pancreatin Pharmacotherapeutic group Agents affecting the digestive system and metabolism More	№ 20, № 50	A09AA02
Pancreazim 10000 Pancreazim 10000 № 20, № 50 Enterosoluble tablets Active ingredient Pancreatin Pharmacotherapeutic group Agents affecting the digestive system and metabolism More	№ 20, № 50	А09АА02
Pancreazim 10000 Pancreazim 10000 № 20, № 50 Active ingredient Pancreatin Pharmacotherapeutic group Agents affecting the digestive system and metabolism More	№ 20, № 50	А09АА02
Papaverine Papaverine 20 mg/ml, 2 ml № 10 Solution for injections Active ingredient Papaverine hydrochloride Pharmacotherapeutic group Agents affecting the digestive system and metabolism More	20 mg/ml, 2 ml № 10	A03AD01
Pyridoxine hydrochloride (vitamin В6) Pyridoxine hydrochloride (vitamin В6) 50 mg/ml, 1 ml № 10 Solution for injections Active ingredient Pyridoxine hydrochloride Pharmacotherapeutic group Agents affecting the digestive system and metabolism More	50 mg/ml, 1 ml № 10	A11HA02
Ranitidine Ranitidine 150 mg № 20 Film-coated tablets Active ingredient Ranitidine hydrochloride Pharmacotherapeutic group Agents affecting the digestive system and metabolism More	150 mg № 20	A02BA02
Ranitidine Ranitidine 150 mg №30 Film-coated tablets Active ingredient Ranitidine hydrochloride Pharmacotherapeutic group Agents affecting the digestive system and metabolism More	150 mg №30	A02BA02
Renalgan Renalgan 5 ml №5 Solution for injections Active ingredient Metamizol natrii, fenpiverinium bromide, pitofenone hydrochloride Pharmacotherapeutic group Agents affecting the digestive system and metabolism More	5 ml №5	A03DA02
Renalgan Renalgan № 10 Tablets Active ingredient Metamizol natrii, fenpiverinium bromide, pitofenone hydrochloride Pharmacotherapeutic group Agents affecting the digestive system and metabolism More	№ 10	A03DA02
Renalgan Renalgan 2 ml №10 Solution for injections Active ingredient Metamizol natrii, fenpiverinium bromide, pitofenone hydrochloride Pharmacotherapeutic group Agents affecting the digestive system and metabolism More	2 ml №10	A03DA02
Renalgan Renalgan №20 Tablets Active ingredient Metamizol natrii, fenpiverinium bromide, pitofenone hydrochloride Pharmacotherapeutic group Agents affecting the digestive system and metabolism More	№20	A03DA02
Retinol acetate (vitamin A) Retinol acetate (vitamin A) 34,4 mg/ml, 10 ml № 1 Oral oil solution Active ingredient Retinol acetate Pharmacotherapeutic group Agents affecting the digestive system and metabolism More	34,4 mg/ml, 10 ml № 1	A11CA01
Revit Revit № 75, № 100 Dragee Active ingredient Comb drug Pharmacotherapeutic group Agents affecting the digestive system and metabolism More	№ 75, № 100	A11BA
Solizym forte Solizym forte № 20 Enterosoluble tablets Active ingredient Microbiological lipase Pharmacotherapeutic group Agents affecting the digestive system and metabolism More	№ 20	A09AA
Stomolik Stomolik 125 ml № 1 Solution for oral cavity Active ingredient Hexetidine Pharmacotherapeutic group Agents affecting the digestive system and metabolism More	125 ml № 1	А01АВ12
Thiamine chloride (vitamin В1) Thiamine chloride (vitamin В1) 50 mg/ml, 1 ml in ampoules № 10 Solution for injections Active ingredient Thiamine hydrochloride Pharmacotherapeutic group Agents affecting the digestive system and metabolism More	50 mg/ml, 1 ml in ampoules № 10	A11DA01

Agents affecting blood system and hemapoiesis

Agents affecting blood system and hemapoiesis

Name	Dosage form	ATC code
Aquaferrol Aquaferrol 10 mg/ml, 125 ml № 1 Syrup Active ingredient Ferric oxide polymaltose complexes Pharmacotherapeutic group Agents affecting blood system and hemapoiesis More	10 mg/ml, 125 ml № 1	В03АВ05
Cyanocobalamin (vitamin В12) Cyanocobalamin (vitamin В12) 0,5 mg/ml, 1 ml № 10 Solution for injections Active ingredient Cyanocobalamin Pharmacotherapeutic group Agents affecting blood system and hemapoiesis More	0,5 mg/ml, 1 ml № 10	B03BA01
Ferrofol Ferrofol № 30 Chewable tablets Active ingredient Ferric oxide polymaltose complexes Pharmacotherapeutic group Agents affecting blood system and hemapoiesis More	№ 30	В03АD04
Folic acid Folic acid 5 mg № 50 Tablets Active ingredient Folic acid Pharmacotherapeutic group Agents affecting blood system and hemapoiesis More	5 mg № 50	B03BB01
Folic acid Folic acid 1 mg № 50 Tablets Active ingredient Folic acid Pharmacotherapeutic group Agents affecting blood system and hemapoiesis More	1 mg № 50	B03BB01
Magnesium sulfate Magnesium sulfate 250 mg/ml, 5 ml № 10 Solution for injections Active ingredient Magnesium sulfate heptahydrate Pharmacotherapeutic group Agents affecting blood system and hemapoiesis More	250 mg/ml, 5 ml № 10	B05XA05
Sodium chloride Sodium chloride 9 mg/ml, 5 ml №10 Solution for injections Active ingredient Sodium chloride Pharmacotherapeutic group Agents affecting blood system and hemapoiesis More	9 mg/ml, 5 ml №10	B05XA03
Tranexamic acid Tranexamic acid 50 mg/ml, 5 ml № 5, № 10, № 100 Solution for injections Active ingredient Tranexamic acid Pharmacotherapeutic group Agents affecting blood system and hemapoiesis More	50 mg/ml, 5 ml № 5, № 10, № 100	B02AA02
Tranexamic acid Tranexamic acid 100 mg/ml, 5 ml № 5, № 10, № 100 Solution for injections Active ingredient Tranexamic acid Pharmacotherapeutic group Agents affecting blood system and hemapoiesis More	100 mg/ml, 5 ml № 5, № 10, № 100	B02AA02
Trombolik-Cardio Trombolik-Cardio 100 mg № 20 Enterosoluble tablets Active ingredient Acetylsalicylic acid Pharmacotherapeutic group Agents affecting blood system and hemapoiesis More	100 mg № 20	B01AC06

Agents affecting cardio-vascular system

Agents affecting cardio-vascular system

Name	Dosage form	ATC code
Accordin Accordin 100 mg/ml, 5 ml № 5, № 10, № 100 Solution for injections Active ingredient 3 (2,2,2-trimethylhydrazinium) propionate dihydrate (meldonium) Pharmacotherapeutic group Agents affecting cardio-vascular system More	100 mg/ml, 5 ml № 5, № 10, № 100	С01ЕВ22
Amiodarone Amiodarone 0,2 g № 30 Tablets Active ingredient Amiodarone hydrochloride Pharmacotherapeutic group Agents affecting cardio-vascular system More	0,2 g № 30	C01BD01
Amlodipine Amlodipine 5 mg №60 Tablets Active ingredient Amlodipine besilate Pharmacotherapeutic group Agents affecting cardio-vascular system More	5 mg №60	C08CA01
Amlodipine Amlodipine 5 mg №90 Tablets Active ingredient Amlodipine besilate Pharmacotherapeutic group Agents affecting cardio-vascular system More	5 mg №90	C08CA01
Amlodipine Amlodipine 10 mg №60 Active ingredient Amlodipine besilate Pharmacotherapeutic group Agents affecting cardio-vascular system More	10 mg №60	C08CA01
Amlodipine Amlodipine 10 mg №90 Active ingredient Amlodipine besilate Pharmacotherapeutic group Agents affecting cardio-vascular system More	10 mg №90	C08CA01
Amlodipine Amlodipine 5 mg № 30 Tablets Active ingredient Amlodipine besilate Pharmacotherapeutic group Agents affecting cardio-vascular system More	5 mg № 30	C08CA01
Amlodipine Amlodipine 10 mg № 30 Tablets Active ingredient Amlodipine besilate Pharmacotherapeutic group Agents affecting cardio-vascular system More	10 mg № 30	C08CA01
Amlodipine 10 Amlodipine 10 10 мг №30 Tablets Active ingredient Amlodipine besilate Pharmacotherapeutic group Agents affecting cardio-vascular system More	10 мг №30	С08С А01
Amlodipine 10 Amlodipine 10 10 mg №60 Tablets Active ingredient Amlodipine besilate Pharmacotherapeutic group Agents affecting cardio-vascular system More	10 mg №60	С08С А01
Amlodipine 5 Amlodipine 5 5 mg №30 Tablets Active ingredient Amlodipine besilate Pharmacotherapeutic group Agents affecting cardio-vascular system More	5 mg №30	С08С А01
Amlodipine 5 Amlodipine 5 5 mg №60 Tablets Active ingredient Amlodipine besilate Pharmacotherapeutic group Agents affecting cardio-vascular system More	5 mg №60	С08С А01
Anaesthesolum Anaesthesolum № 5, № 10 Suppositories Active ingredient Benzobarbital, bismuth subgallate, zinc oxide, menthol Pharmacotherapeutic group Agents affecting cardio-vascular system More	№ 5, № 10	C05AD
Ascorutin Ascorutin № 50, № 800 Tablets Active ingredient Ascorbic acid (vitamin C), rutoside Pharmacotherapeutic group Agents affecting cardio-vascular system More	№ 50, № 800	C05CA51
Beladonna Beladonna 0,015 g № 10 Rectal suppositories Active ingredient Beladonna dense extract Pharmacotherapeutic group Agents affecting cardio-vascular system More	0,015 g № 10	C05AX
Bethiolum Bethiolum № 10 Rectal suppositories Active ingredient Comb drug Pharmacotherapeutic group Agents affecting cardio-vascular system More	№ 10	C05AX03
Enalapril Enalapril 0,01 g № 20 Tablets Active ingredient Enalapril maleate Pharmacotherapeutic group Agents affecting cardio-vascular system More	0,01 g № 20	C09AA02
Enalapril Enalapril 0,01 g № 90 Tablets Active ingredient Enalapril maleate Pharmacotherapeutic group Agents affecting cardio-vascular system More	0,01 g № 90	C09AA02
Enalapril Enalapril 0,01 g № 50 Tablets Active ingredient Enalapril maleate Pharmacotherapeutic group Agents affecting cardio-vascular system More	0,01 g № 50	C09AA02
Larginus Larginus 200 mg/ml Oral solution Active ingredient Arginine aspartate Pharmacotherapeutic group Agents affecting cardio-vascular system More	100 мл	С01E
Lekdona Lekdona 15 mg № 10 Active ingredient Pharmacotherapeutic group Agents affecting cardio-vascular system More	15 mg № 10	C05AX
Leksol Leksol № 5, № 10 Active ingredient Benzobarbital, bismuth subgallate, zinc oxide, menthol Pharmacotherapeutic group Agents affecting cardio-vascular system More	№ 5, № 10	C05AD
Nicotinic acid Nicotinic acid 50 mg № 50 Tablets Active ingredient Nicotinic acid Pharmacotherapeutic group Agents affecting cardio-vascular system More	50 mg № 50	C04AC01
Nifedipine Nifedipine 20 mg № 50 Film-coated tablets Active ingredient Nifedipine Pharmacotherapeutic group Agents affecting cardio-vascular system More	20 mg № 50	C08CA05
Nifedipine Nifedipine 10 mg № 50 Film-coated tablets Active ingredient Nifedipine Pharmacotherapeutic group Agents affecting cardio-vascular system More	10 mg № 50	C08CA05
Nitroglycerine Nitroglycerine 0,5 mg № 40 Sublingual tablets Active ingredient Nitroglycerine 2% on lactose Pharmacotherapeutic group Agents affecting cardio-vascular system More	0,5 mg № 40	C01DA02
Nitrogranulong Nitrogranulong 5,2 mg № 10, № 50 Prolonged release tablets Active ingredient Nitroglycerine 2% on lactose Pharmacotherapeutic group Agents affecting cardio-vascular system More	5,2 mg № 10, № 50	C01DA02
Nitrogranulong Nitrogranulong 2,9 mg № 10, № 50 Prolonged release tablets Active ingredient Nitroglycerine 2% on lactose Pharmacotherapeutic group Agents affecting cardio-vascular system More	2,9 mg № 10, № 50	C01DA02
Oftalek Oftalek 10 mg/ml 1 ml №10 Solution for injections Active ingredient Methylethylpiridinol hydrochloride Pharmacotherapeutic group Agents affecting cardio-vascular system More	10 mg/ml 1 ml №10	С05СX
Pentoxifylline Pentoxifylline 100 mg № 10, № 50 Enterosoluble tablets Active ingredient Pentoxifylline Pharmacotherapeutic group Agents affecting cardio-vascular system More	100 mg № 10, № 50	C04AD03
Propolis Propolis 0,1 g № 5, № 10 Suppositories Active ingredient Propolis Pharmacotherapeutic group Agents affecting cardio-vascular system More	0,1 g № 5, № 10	C05AX
Riboxin Riboxin 200 mg № 10, № 50 Film-coated tablets Active ingredient Riboxin (inosine) Pharmacotherapeutic group Agents affecting cardio-vascular system More	200 mg № 10, № 50	C01EB
Spironolactone Spironolactone 25 mg №20 Tablets Active ingredient Spironolactone Pharmacotherapeutic group Agents affecting cardio-vascular system More	25 mg №20	C03D A01
Spironolactone Spironolactone 50 mg №20 Tablets Active ingredient Spironolactone Pharmacotherapeutic group Agents affecting cardio-vascular system More	50 mg №20	C03D A01
Spironolactone Spironolactone 100 mg №20 Tablets Active ingredient Spironolactone Pharmacotherapeutic group Agents affecting cardio-vascular system More	100 mg №20	C03D A01
Spironolactone Spironolactone 25 mg №50 Active ingredient Spironolactone Pharmacotherapeutic group Agents affecting cardio-vascular system More	25 mg №50	C03D A01
Spironolactone Spironolactone 50 mg №50 Tablets Active ingredient Spironolactone Pharmacotherapeutic group Agents affecting cardio-vascular system More	50 mg №50	C03D A01
Spironolactone Spironolactone 100 mg №50 Tablets Active ingredient Spironolactone Pharmacotherapeutic group Agents affecting cardio-vascular system More	100 mg №50	C03D A01
Spironolactone Spironolactone 100 mg №30 Tablets Active ingredient Spironolactone Pharmacotherapeutic group Agents affecting cardio-vascular system More	100 mg №30	C03D A01
Spironolactone Spironolactone 50 mg №30 Tablets Active ingredient Spironolactone Pharmacotherapeutic group Agents affecting cardio-vascular system More	50 mg №30	C03D A01
Spironolactone Spironolactone 25 mg №30 Tablets Active ingredient Spironolactone Pharmacotherapeutic group Agents affecting cardio-vascular system More	25 mg №30	C03D A01
Torasemide Torasemide 5 mg/ml 2 ml, 4 ml № 5, № 10, № 100 Solution for injections Active ingredient Torasemide Pharmacotherapeutic group Agents affecting cardio-vascular system More	5 mg/ml 2 ml, 4 ml № 5, № 10, № 100	C03CA04

Dermatological agents

Dermatological agents

Name	Dosage form	ATC code
Aecol Aecol 50 ml № 1 Oil solution Active ingredient Retinol (vit A), tocopherol (vit E), menadione (vit K3), betacarotene Pharmacotherapeutic group Dermatological agents More	50 ml № 1	D03AX
Aecol Aecol 50 ml, 100 ml Active ingredient Retinol acetate, alpha-tocopheryl acetate, menadione, beta-carotene Pharmacotherapeutic group Dermatological agents More	50 ml, 100 ml	D03АX
Aecol Aecol 100 ml Oil solution Active ingredient Retinol (vit A), tocopherol (vit E), menadione (vit K3), betacarotene Pharmacotherapeutic group Dermatological agents More	100 ml № 1	D03AX
Iodine Pechaevskiy Iodine Pechaevskiy 10 % 30 ml № 1 Solution for external administration Active ingredient Povidone/Iodine Pharmacotherapeutic group Dermatological agents More	10 % 30 ml № 1	D08AG02
Iodine Pechaevskiy Iodine Pechaevskiy 10 % 120 ml № 1 Solution for external administration Active ingredient Povidone/Iodine Pharmacotherapeutic group Dermatological agents More	10 % 120 ml № 1	D08AG02
Iodine Pechaevskiy Iodine Pechaevskiy 10 % 1000 ml № 1 Solution for external administration Active ingredient Povidone/Iodine Pharmacotherapeutic group Dermatological agents More	10 % 1000 ml № 1	D08AG02
Naftiderile Naftiderile 10 ml № 1 Dermal solution Active ingredient Naphthyfin hydrochloride Pharmacotherapeutic group Dermatological agents More	10 ml № 1	D01AE22

Agents affecting genitourinary system and reproductive hormones

Agents affecting genitourinary system and reproductive hormones

Name	Dosage form	ATC code
Chinofucin Chinofucin 0,015 g № 5, № 10 Vaginal suppositories Active ingredient Chlorquinaldol Pharmacotherapeutic group Agents affecting genitourinary system and reproductive hormones More	0,015 g № 5, № 10	G01AC03
Eucolec Eucolec 0,05 g № 5, № 10 Suppositories Active ingredient Chlorophyllipt dense extract Pharmacotherapeutic group Agents affecting genitourinary system and reproductive hormones More	0,05 g № 5, № 10	G01AX
Klioron Klioron 16 mg № 10 Vaginal suppositories Active ingredient Chlorhexidine digluconate Pharmacotherapeutic group Agents affecting genitourinary system and reproductive hormones More	16 mg № 10	G01AX
Klioron V Klioron V 16 mg № 10 Active ingredient Pharmacotherapeutic group Agents affecting genitourinary system and reproductive hormones More	16 mg № 10	G01AX
Lekfucin Lekfucin 15 mg № 5, № 10 Active ingredient Chlorquinaldol Pharmacotherapeutic group Agents affecting genitourinary system and reproductive hormones More	15 mg № 5, № 10	G01AС03
Leknazole Leknazole 150 mg № 3 Active ingredient Econazole nitrate Pharmacotherapeutic group Agents affecting genitourinary system and reproductive hormones More	150 mg № 3	G01АF05
Lekvolek Lekvolek 50 mg № 5, № 10 Active ingredient Pharmacotherapeutic group Agents affecting genitourinary system and reproductive hormones More	50 mg № 5, № 10	G01AX
Levoklek Levoklek 50 mg № 5, № 10 Active ingredient Chlorophyllipt dense extract Pharmacotherapeutic group Agents affecting genitourinary system and reproductive hormones More	50 mg № 5, № 10	G01AX
Omix Omix 0,4 mg № 10, № 30 Hard capsules Active ingredient Tamsulosin hydrochloride Pharmacotherapeutic group Agents affecting genitourinary system and reproductive hormones More	0,4 mg № 10, № 30	G04CA02
Omix Omix 0.4 mg № 10, № 30 Active ingredient Tamsulosin hydrochloride Pharmacotherapeutic group Agents affecting genitourinary system and reproductive hormones More	0.4 mg № 10, № 30	G04C A02
Potentiale Potentiale 50 mg № 2 Film-coated tablets Active ingredient Sildenafil citrate Pharmacotherapeutic group Agents affecting genitourinary system and reproductive hormones More	50 mg № 2	G04BE03
Potentiale Potentiale 50 mg №4 Film-coated tablets Active ingredient Sildenafil citrate Pharmacotherapeutic group Agents affecting genitourinary system and reproductive hormones More	50 mg №4	G04BE03
Potentiale Potentiale 100 mg №2 Film-coated tablets Active ingredient Sildenafil citrate Pharmacotherapeutic group Agents affecting genitourinary system and reproductive hormones More	100 mg №2	G04BE03
Potentiale Potentiale 100 mg №4 Film-coated tablets Active ingredient Sildenafil citrate Pharmacotherapeutic group Agents affecting genitourinary system and reproductive hormones More	100 mg №4	G04BE03
Potentiale Potentiale 100 mg № 1 Film-coated tablets Active ingredient Sildenafil citrate Pharmacotherapeutic group Agents affecting genitourinary system and reproductive hormones More	100 mg № 1	G04BE03
Potentiale Potentiale 50 mg № 1 Film-coated tablets Active ingredient Sildenafil citrate Pharmacotherapeutic group Agents affecting genitourinary system and reproductive hormones More	50 mg № 1	G04BE03
Povidin Povidin 0,3 g № 5, № 10 Vaginal suppositories Active ingredient Povidone/Iodine Pharmacotherapeutic group Agents affecting genitourinary system and reproductive hormones More	0,3 g № 5, № 10	G01AX11
Prostan Prostan 5 mg № 10, № 30 Film-coated tablets Active ingredient Finasteride Pharmacotherapeutic group Agents affecting genitourinary system and reproductive hormones More	5 mg № 10, № 30	G04CB01
Prostatilen Prostatilen 0,03 g №5 Rectal suppositories Active ingredient Prostatilen Pharmacotherapeutic group Agents affecting genitourinary system and reproductive hormones More	0,03 g №5	G04CX
Prostatilen Prostatilen 0,03 g № 10 Rectal suppositories Active ingredient Prostatilen Pharmacotherapeutic group Agents affecting genitourinary system and reproductive hormones More	0,03 g № 10	G04CX
Prostatilen Prostatilen 2 ml № 5, № 10 Solution for injections Active ingredient Prostatilen Pharmacotherapeutic group Agents affecting genitourinary system and reproductive hormones More	2 ml № 5, № 10	G04СX
Prostatilen-Zinc Prostatilen-Zinc №10 Rectal suppositories Active ingredient Comb drug Pharmacotherapeutic group Agents affecting genitourinary system and reproductive hormones More	№10	G04CX
Prostatilen-Zinc Prostatilen-Zinc № 5 Rectal suppositories Active ingredient Comb drug Pharmacotherapeutic group Agents affecting genitourinary system and reproductive hormones More	№ 5	G04CX
Santekvin Santekvin 0,15 g № 3 Vaginal suppositories Active ingredient Econazole nitrate Pharmacotherapeutic group Agents affecting genitourinary system and reproductive hormones More	0,15 g № 3	G01AF05

Hormone drugs for systemic use

Name	Dosage form	ATC code
Bemedozon Bemedozon 4 mg/ml, 1 ml № 5, № 10, № 100 Solution for injections Active ingredient Betamethasone Pharmacotherapeutic group Hormone drugs for systemic use More	4 mg/ml, 1 ml № 5, № 10, № 100	Н02АВ01
Dexamethasone Dexamethasone 4 mg/ml, 1 ml № 5 Solution for injections Active ingredient Dexamethasone sodium phosphate Pharmacotherapeutic group Hormone drugs for systemic use More	4 mg/ml, 1 ml № 5	H02AB02
Lekthasone Lekthasone 4 mg/1 ml № 5, № 100 Active ingredient Dexamethasone sodium phosphate Pharmacotherapeutic group Hormone drugs for systemic use More	4 mg/1 ml № 5, № 100	H02AB02

Antimicrobial agents for systemic use

Name	Dosage form	ATC code
Aciclovir Aciclovir 0,2 g № 10, № 20 Tablets Active ingredient Aciclovir Pharmacotherapeutic group Antimicrobial agents for systemic use More	0,2 g № 10, № 20	J05AB01
Amicacin sulfate Amicacin sulfate 50 mg/ml, 2 ml № 1 Solution for injections Active ingredient Amikacin sulfate Pharmacotherapeutic group Antimicrobial agents for systemic use More	50 mg/ml, 2 ml № 1	J01GB06
Amikacin sulfate Amikacin sulfate 250 mg/ml, 2 ml № 1 Solution for injections Active ingredient Amikacin sulfate Pharmacotherapeutic group Antimicrobial agents for systemic use More	250 mg/ml, 2 ml № 1	J01GB06
Amikacin sulfate Amikacin sulfate 250 mg/ml, 4 ml № 1 Solution for injections Active ingredient Amikacin sulfate Pharmacotherapeutic group Antimicrobial agents for systemic use More	250 mg/ml, 4 ml № 1	J01GB06
Cefazolin Cefazolin 1,0 g № 5 Powder for solution for injections Active ingredient Cefazolin sodium Pharmacotherapeutic group Antimicrobial agents for systemic use More	1,0 g № 5	J01DB04
Cefazolin Cefazolin 1,0 g № 1 Powder for solution for injections Active ingredient Cefazolin sodium Pharmacotherapeutic group Antimicrobial agents for systemic use More	1,0 g № 1	J01DB04
Cefazolin 1000 Cefazolin 1000 1,0 g № 1 Powder for solution for injections Active ingredient Cefazolin sodium Pharmacotherapeutic group Antimicrobial agents for systemic use More	1,0 g № 1	J01DB04
Cefazolin 1000 Cefazolin 1000 1,0 g № 5 Powder for solution for injections Active ingredient Cefazolin sodium Pharmacotherapeutic group Antimicrobial agents for systemic use More	1,0 g № 5	J01DB04
Cefazolin combi Cefazolin combi 0,5 g № 1, № 10, № 50 Powder for solution for injections Active ingredient Cefazolin sodium Pharmacotherapeutic group Antimicrobial agents for systemic use More	0,5 g № 1, № 10, № 50	J01DB04
Cefepime Cefepime 1 g № 1 Powder for solution for injections Active ingredient Cefepime hydrochloride Pharmacotherapeutic group Antimicrobial agents for systemic use More	1 g № 1	J01DE01
Cefepime with solvent Cefepime with solvent 1,0 г № 1 Powder for solution for injections Active ingredient Cefepime hydrochloride Pharmacotherapeutic group Antimicrobial agents for systemic use More	1,0 г № 1	J01DE01
Cefotaxime Cefotaxime 1,0 g № 1 Powder for solution for injections Active ingredient Cefotaxime Pharmacotherapeutic group Antimicrobial agents for systemic use More	1,0 g № 1	J01DD01
Cefotaxime Cefotaxime 1,0 g № 50 Powder for solution for injections Active ingredient Cefotaxime Pharmacotherapeutic group Antimicrobial agents for systemic use More	1,0 g № 50	J01DD01
Cefotaxime Cefotaxime 1,0 g № 5 Powder for solution for injections Active ingredient Cefotaxime Pharmacotherapeutic group Antimicrobial agents for systemic use More	1,0 g № 5	J01DD01
Cefotaxime Cefotaxime 1,0 g № 1 Powder for solution for injections Active ingredient Cefotaxime sodium Pharmacotherapeutic group Antimicrobial agents for systemic use More	1,0 g № 1	J01DD01
Cefotaxime Cefotaxime 1,0 g № 5 Powder for solution for injections Active ingredient Cefotaxime sodium Pharmacotherapeutic group Antimicrobial agents for systemic use More	1,0 g № 5	J01DD01
Cefotaxime + Water for injection Cefotaxime + Water for injection 1 vial and 1 ampoule Powder for solution for injections Active ingredient Cefotaxime Pharmacotherapeutic group Antimicrobial agents for systemic use More	1 vial and 1 ampoule	J01D D01
Cefotaxime combi Cefotaxime combi 0,5 g №1 Powder for solution for injections Active ingredient Cefotaxime Pharmacotherapeutic group Antimicrobial agents for systemic use More	0,5 g №1	J01DD01
Ceftazidime Ceftazidime 1,0 g № 1, № 5, № 50 Powder for solution for injections Active ingredient Ceftazidime pentahydrate Pharmacotherapeutic group Antimicrobial agents for systemic use More	1,0 g № 1, № 5, № 50	J01DD02
Ceftriaxone Ceftriaxone 1,0 g № 5 Solution for injections Active ingredient Ceftriaxone sodium Pharmacotherapeutic group Antimicrobial agents for systemic use More	1,0 g № 5	J01DD04
Ceftriaxone Ceftriaxone 1,0 g №1 Powder for solution for injections Active ingredient Ceftriaxone sodium Pharmacotherapeutic group Antimicrobial agents for systemic use More	1,0 g №1	J01DD04
Ceftriaxone Ceftriaxone 1,0 g №5 Powder for solution for injections Active ingredient Ceftriaxone sodium Pharmacotherapeutic group Antimicrobial agents for systemic use More	1,0 g №5	J01DD04
Ceftriaxone Ceftriaxone 1,0 g №50 Powder for solution for injections Active ingredient Ceftriaxone sodium Pharmacotherapeutic group Antimicrobial agents for systemic use More	1,0 g №50	J01DD04
Ceftriaxone Ceftriaxone 1,0 g №50 Powder for solution for injections Active ingredient Ceftriaxone sodium Pharmacotherapeutic group Antimicrobial agents for systemic use More	1,0 g №50	J01DD04
Ceftriaxone Ceftriaxone 1,0 g № 1 Solution for injections Active ingredient Ceftriaxone sodium Pharmacotherapeutic group Antimicrobial agents for systemic use More	1,0 g № 1	J01DD04
Ceftriaxone + Lidocaine Ceftriaxone + Lidocaine 1 vial and 1 ampoule Powder for solution for injections Active ingredient Ceftriaxone Pharmacotherapeutic group Antimicrobial agents for systemic use More	1 vial and 1 ampoule	J01D D04
Ceftriaxone + Water for injection Ceftriaxone + Water for injection 1 vial and 1 ampoule Powder for solution for injections Active ingredient Ceftriaxone Pharmacotherapeutic group Antimicrobial agents for systemic use More	1 vial and 1 ampoule	J01D D04
Ceftriaxone 500 Ceftriaxone 500 0,5 g № 1, № 10, № 50 Powder for solution for injections Active ingredient Ceftriaxone Pharmacotherapeutic group Antimicrobial agents for systemic use More	0,5 g № 1, № 10, № 50	J01D D04
Cefuroxime Cefuroxime 0,75 g №1 Powder for solution for injections Active ingredient Cefuroxime Pharmacotherapeutic group Antimicrobial agents for systemic use More	0,75 g №1	J01DC02
Cefuroxime Cefuroxime 0,75 g №1 Powder for solution for injections Active ingredient Cefuroxime Pharmacotherapeutic group Antimicrobial agents for systemic use More	0,75 g №1	J01DC02
Cefuroxime Cefuroxime 1,5 g №1 Powder for solution for injections Active ingredient Cefuroxime Pharmacotherapeutic group Antimicrobial agents for systemic use More	1,5 g №1	J01DC02
Cefuroxime Cefuroxime 1,5 g № 1 Powder for solution for injections Active ingredient Cefuroxime Pharmacotherapeutic group Antimicrobial agents for systemic use More	1,5 g № 1	J01DС02
Cefuroxime + Water for injection Cefuroxime + Water for injection 1 vial and 1 ampoule Powder for solution for injections Active ingredient Cefuroxime Pharmacotherapeutic group Antimicrobial agents for systemic use More	1 vial and 1 ampoule	J01D С02
Cilpen Cilpen 500 mg/500 mg № 10 Powder for solution for infusion Active ingredient Imipenem and cilastatin Pharmacotherapeutic group Antimicrobial agents for systemic use More	500 mg/500 mg № 10	J01DH51
Cilpen Cilpen 500 mg/500 mg № 1 Powder for solution for infusion Active ingredient Imipenem and cilastatin Pharmacotherapeutic group Antimicrobial agents for systemic use More	500 mg/500 mg № 1	J01DH51
Ciprofloxacin Ciprofloxacin 500 mg № 10 Film-coated tablets Active ingredient Ciprofloxacin hydrochloride Pharmacotherapeutic group Antimicrobial agents for systemic use More	500 mg № 10	J01MA02
Ciprofloxacin Ciprofloxacin 250 mg № 10 Film-coated tablets Active ingredient Ciprofloxacin hydrochloride Pharmacotherapeutic group Antimicrobial agents for systemic use More	250 mg № 10	J01MA02
Cycloserine Cycloserine 250 mg № 30 Hard capsules Active ingredient Cycloserine Pharmacotherapeutic group Antimicrobial agents for systemic use More	250 mg № 30	J04AВ01
Fluconazole Fluconazole 150 mg №2 Film-coated tablets Active ingredient Fluconazole Pharmacotherapeutic group Antimicrobial agents for systemic use More	150 mg №2	J02AC01
Fluconazole Fluconazole 50 mg № 10 Film-coated tablets Active ingredient Fluconazole Pharmacotherapeutic group Antimicrobial agents for systemic use More	50 mg № 10	J02AC02
Fluconazole Fluconazole 100 mg № 10 Film-coated tablets Active ingredient Fluconazole Pharmacotherapeutic group Antimicrobial agents for systemic use More	100 mg № 10	J02AC01
Fluconazole Fluconazole 150 mg № 1 Film-coated tablets Active ingredient Fluconazole Pharmacotherapeutic group Antimicrobial agents for systemic use More	150 mg № 1	J02AC01
Lamivudine Lamivudine 10 mg/ml, 240 ml № 1 Oral solution Active ingredient Lamivudine Pharmacotherapeutic group Antimicrobial agents for systemic use More	10 mg/ml, 240 ml № 1	J05А F05
Lamivudine Lamivudine 150 mg № 60 Film-coated tablets Active ingredient Lamivudine Pharmacotherapeutic group Antimicrobial agents for systemic use More	150 mg № 60	J05AF05
Lazivudine Lazivudine № 60 Film-coated tablets Active ingredient Comb drug Pharmacotherapeutic group Antimicrobial agents for systemic use More	№ 60	J05AR01
Lekcef + water for injections Lekcef + water for injections 1 vial and 1 ampoule Active ingredient Ceftriaxone Pharmacotherapeutic group Antimicrobial agents for systemic use More	1 vial and 1 ampoule	J01DD04
Lekcef + Water for injections Lekcef + Water for injections 1 vial and 1 ampoule Active ingredient Ceftriaxone Pharmacotherapeutic group Antimicrobial agents for systemic use More	1 vial and 1 ampoule	J01DD04
Lekcin Lekcin 200 mg № 10 Active ingredient Ofloxacin Pharmacotherapeutic group Antimicrobial agents for systemic use More	200 mg № 10	J01MA01
Lekfazolin Lekfazolin 1,0 g № 1 Active ingredient Pharmacotherapeutic group Antimicrobial agents for systemic use More	1,0 g № 1	J01DB04
Lektaxime Lektaxime 1.0 g № 1 Active ingredient Cefotaxime Pharmacotherapeutic group Antimicrobial agents for systemic use More	1.0 g № 1	J01DD01
Lektaxime + Water for injection Lektaxime + Water for injection 1 vial and 1 ampoule Active ingredient Cefotaxime Pharmacotherapeutic group Antimicrobial agents for systemic use More	1 vial and 1 ampoule	J01DD01
Levofloxacin Levofloxacin 250 mg № 10 Film-coated tablets Active ingredient Levofloxacin hemihydrate Pharmacotherapeutic group Antimicrobial agents for systemic use More	250 mg № 10	J01MA12
Levofloxacin Levofloxacin 500 mg № 10 Film-coated tablets Active ingredient Levofloxacin hemihydrate Pharmacotherapeutic group Antimicrobial agents for systemic use More	500 mg № 10	J01MA12
Meropenem Meropenem 1,0 g №1 Powder for solution for injections Active ingredient Meropenem trihydrate Pharmacotherapeutic group Antimicrobial agents for systemic use More	1,0 g №1	J01DH02
Meropenem Meropenem 1,0 g № 1 Powder for solution for injections Active ingredient Meropenem trihydrate Pharmacotherapeutic group Antimicrobial agents for systemic use More	1,0 g № 1	J01DH02
Moxifloxacin Moxifloxacin 400 мг №7 Film-coated tablets Active ingredient Moxifloxacin Pharmacotherapeutic group Antimicrobial agents for systemic use More	400 мг №7	J01MA14
Moxifloxacin Moxifloxacin 400 mg №10 Film-coated tablets Active ingredient Moxifloxacin Pharmacotherapeutic group Antimicrobial agents for systemic use More	400 mg №10	J01MA14
Moxifloxacin Moxifloxacin 400 mg №5 Film-coated tablets Active ingredient Moxifloxacin Pharmacotherapeutic group Antimicrobial agents for systemic use More	400 mg №5	J01MA14
Nitroxoline Nitroxoline 50 mg № 10, № 50 Film-coated tablets Active ingredient Nitroxoline Pharmacotherapeutic group Antimicrobial agents for systemic use More	50 mg № 10, № 50	J01XX07
Ofloxacin Ofloxacin 0,2 g № 10 Tablets Active ingredient Ofloxacin Pharmacotherapeutic group Antimicrobial agents for systemic use More	0,2 g № 10	J01MA01
Promocef Promocef 1,0 g № 1, № 5 Powder for solution for injections Active ingredient Ceftriaxone sodium Pharmacotherapeutic group Antimicrobial agents for systemic use More	1,0 g № 1, № 5	J01DD04
Protech Protech 250 mg № 50, № 500 Film-coated tablets Active ingredient Prothionamide Pharmacotherapeutic group Antimicrobial agents for systemic use More	250 mg № 50, № 500	J04AD01
Sodium aminosalicylate Sodium aminosalicylate 0,8 g/1g, 100 g № 1 Enterosoluble granules Active ingredient Pharmacotherapeutic group Antimicrobial agents for systemic use More	0,8 g/1g, 100 g № 1	J04AA02
Terizidone Terizidone 250 mg № 10 Hard capsules Active ingredient Terizidone Pharmacotherapeutic group Antimicrobial agents for systemic use More	250 mg № 10	J04AK03
Triseptol Triseptol 100 mg/20 mg № 20 Tablets Active ingredient Comb drug Pharmacotherapeutic group Antimicrobial agents for systemic use More	100 mg/20 mg № 20	J01EE01
Triseptol Triseptol 400 mg/80 mg № 20 Tablets Active ingredient Comb drug Pharmacotherapeutic group Antimicrobial agents for systemic use More	400 mg/80 mg № 20	J01EE01
Urosept Urosept 0,2 g № 10 Suppositories Active ingredient Pipemidic acid trihydrate Pharmacotherapeutic group Antimicrobial agents for systemic use More	0,2 g № 10	J01MB04
Zidovudine Zidovudine 10 mg/ml 200 ml Oral solution Active ingredient Zidovudine Pharmacotherapeutic group Antimicrobial agents for systemic use More	10 mg/ml 200 ml	J05AF01

Antineoplastic and immunomodulating agents

Agents affecting musculo-skeletal system

Agents affecting musculo-skeletal system

Name	Dosage form	ATC code
Blockpain Blockpain 30 mg/ml, 1 ml №10 Solution for injections Active ingredient Ketorolac tromethamine Pharmacotherapeutic group Agents affecting musculo-skeletal system More	30 mg/ml, 1 ml №10	M01AB15
Desket Desket 25 mg/ml, 2 ml № 10 Solution for injections Active ingredient Dexketoprofen Pharmacotherapeutic group Agents affecting musculo-skeletal system More	25 mg/ml, 2 ml № 10	M01AE17
Diclofenac Diclofenac 0,1 g № 10 Rectal suppositories Active ingredient Diclofenac sodium Pharmacotherapeutic group Agents affecting musculo-skeletal system More	0,1 g № 10	M01AB05
Diclofenac Diclofenac 25 mg/ml, 3 ml №5 Solution for injections Active ingredient Diclofenac sodium Pharmacotherapeutic group Agents affecting musculo-skeletal system More	25 mg/ml, 3 ml №5	M01AB05
Ibuprofen Ibuprofen 200 mg № 50 Film-coated tablets Active ingredient Ibuprofen Pharmacotherapeutic group Agents affecting musculo-skeletal system More	200 mg № 50	M01AE01
Ibuprofen 200 Ibuprofen 200 200 mg № 10, № 50, № 900 Active ingredient Ibuprofen Pharmacotherapeutic group Agents affecting musculo-skeletal system More	200 mg № 10, № 50, № 900	М01А Е01
Ibuprofen 400 Ibuprofen 400 400 mg № 50 Film-coated tablets Active ingredient Ibuprofen Pharmacotherapeutic group Agents affecting musculo-skeletal system More	400 mg № 50	М01АЕ01
Ibuprofen 400 Ibuprofen 400 400 mg №10 Film-coated tablets Active ingredient Ibuprofen Pharmacotherapeutic group Agents affecting musculo-skeletal system More	400 mg №10	М01АЕ01
Ibuprofen 400 Ibuprofen 400 400 mg №20 Film-coated tablets Active ingredient Ibuprofen Pharmacotherapeutic group Agents affecting musculo-skeletal system More	400 mg №20	М01АЕ01
Ibuprofen 400 Ibuprofen 400 400 mg № 10, №20, № 50 Active ingredient Ibuprofen Pharmacotherapeutic group Agents affecting musculo-skeletal system More	400 mg № 10, №20, № 50	M01A E01
Inflamine Inflamine 0,015 g № 10 Rectal suppositories Active ingredient Meloxicam Pharmacotherapeutic group Agents affecting musculo-skeletal system More	0,015 g № 10	M01AC06
Inflamine Inflamine 15 mg/1,5 ml in ampoule № 5 Solution for injections Active ingredient Meloxicam Pharmacotherapeutic group Agents affecting musculo-skeletal system More	15 mg/1,5 ml in ampoule № 5	М01АС06
Ketalgin Ketalgin 0,01 g, № 10 Tablets Active ingredient Ketorolac tromethamine Pharmacotherapeutic group Agents affecting musculo-skeletal system More	0,01 g, № 10	M01AB15
Lekfenac Lekfenac 100 mg № 10 Active ingredient Pharmacotherapeutic group Agents affecting musculo-skeletal system More	100 mg № 10	M01AB05
Lekfenac Lekfenac 75 mg/3 ml № 5, № 100 Active ingredient Diclofenac sodium Pharmacotherapeutic group Agents affecting musculo-skeletal system More	75 mg/3 ml № 5, № 100	М01АВ05
Lektalgin Lektalgin 30 mg/ml 1 ml № 10, № 100 Active ingredient Ketorolac tromethamine Pharmacotherapeutic group Agents affecting musculo-skeletal system More	30 mg/ml 1 ml № 10, № 100	M01AB15
Meloxicam Meloxicam 0,0075 g № 10 ,№ 20 Tablets Active ingredient Meloxicam Pharmacotherapeutic group Agents affecting musculo-skeletal system More	0,0075 g № 10 ,№ 20	M01AC06
Meloxicam Meloxicam 0,015 g № 10, № 20 Tablets Active ingredient Meloxicam Pharmacotherapeutic group Agents affecting musculo-skeletal system More	0,015 g № 10, № 20	M01AC06
Nimesulide Nimesulide 0,1 g № 10, № 30 Tablets Active ingredient Nimesulide Pharmacotherapeutic group Agents affecting musculo-skeletal system More	0,1 g № 10, № 30	M01AX17
Ortophen Ortophen 25 mg № 10, № 30 Enterosoluble tablets Active ingredient Diclofenac sodium Pharmacotherapeutic group Agents affecting musculo-skeletal system More	25 mg № 10, № 30	M01AB05
Zoledronic acid Zoledronic acid 0,8 mg/ml, 5 ml № 1, № 5, № 10 Concentrate for solution for infusion Active ingredient Zoledronic acid Pharmacotherapeutic group Agents affecting musculo-skeletal system More	0,8 mg/ml, 5 ml № 1, № 5, № 10	М05ВА08

Agents affecting the nervous system

Agents affecting the nervous system

Name	Dosage form	ATC code
Acetylsalicylic acid Acetylsalicylic acid 500 mg № 10 Tablets Active ingredient Acetylsalicylic acid Pharmacotherapeutic group Agents affecting the nervous system More	500 mg № 10	N02BA01
Alzhmerat Alzhmerat 600 mg/7 ml № 10 Oral solution Active ingredient Choline alfoscerate Pharmacotherapeutic group Agents affecting the nervous system More	600 mg/7 ml № 10	N07A X02
Alzhmerat Alzhmerat 250 mg/ml, 4 ml № 5 Solution for injections Active ingredient Choline alfoscerate Pharmacotherapeutic group Agents affecting the nervous system More	250 mg/ml, 4 ml № 5	N07AX02
Amitriptylline Amitriptylline 25 mg № 50, № 1000 Film-coated tablets Active ingredient Amitriptylline Pharmacotherapeutic group Agents affecting the nervous system More	25 mg № 50, № 1000	N06AA09
Analgin Analgin 500 mg/ml, 2 ml № 10 Solution for injections Active ingredient Metamizole sodium Pharmacotherapeutic group Agents affecting the nervous system More	500 mg/ml, 2 ml № 10	N02BB02
Analgin for children Analgin for children 0,1 g № 10 Rectal suppositories Active ingredient Metamizole sodium Pharmacotherapeutic group Agents affecting the nervous system More	0,1 g № 10	N02BB02
Analgin for children Analgin for children 0,25 g № 10 Rectal suppositories Active ingredient Metamizole sodium Pharmacotherapeutic group Agents affecting the nervous system More	0,25 g № 10	N02BB02
Azaleptol Azaleptol 100 mg №50 Tablets Active ingredient Clozapine Pharmacotherapeutic group Agents affecting the nervous system More	100 mg №50	N05AH02
Azaleptol Azaleptol 25 mg № 50 Tablets Active ingredient Clozapine Pharmacotherapeutic group Agents affecting the nervous system More	25 mg № 50	N05AH02
Barviton Barviton 5 mg/ml, 2 ml № 10 Solution for injections Active ingredient Vinpocetine Pharmacotherapeutic group Agents affecting the nervous system More	5 mg/ml, 2 ml № 10	N06BX18
Carbamazepine Carbamazepine 200 mg №20 Tablets Active ingredient Carbamazepine Pharmacotherapeutic group Agents affecting the nervous system More	200 mg №20	N03AF01
Carbamazepine Carbamazepine 200 mg № 50 Tablets Active ingredient Carbamazepine Pharmacotherapeutic group Agents affecting the nervous system More	200 mg № 50	N03AF01
Cilityn Cilityn 250 mg/ml, 4 ml № 5, № 10, № 100 Solution for injections Active ingredient Citicoline Pharmacotherapeutic group Agents affecting the nervous system More	250 mg/ml, 4 ml № 5, № 10, № 100	N06BX06
Cinnarizine Cinnarizine 0,025 g № 25, № 50 Tablets Active ingredient Cinnarizine Pharmacotherapeutic group Agents affecting the nervous system More	0,025 g № 25, № 50	N07CA02
Cylityne Cylityne 100 mg, 30 ml Oral solution Active ingredient Citicoline Pharmacotherapeutic group Agents affecting the nervous system More	100 mg, 30 ml	N06BX06
Epigaba Epigaba 300 mg №100 Hard capsules Active ingredient Gabapentin Pharmacotherapeutic group Agents affecting the nervous system More	300 mg №100	N03AX12
Epigaba Epigaba 300 mg № 20 Hard capsules Active ingredient Gabapentin Pharmacotherapeutic group Agents affecting the nervous system More	300 mg № 20	N03AX12
Ipidacord Ipidacord 15 mg/ml 1 ml №10 Solution for injections Active ingredient Ipidacrine hydrochloride Pharmacotherapeutic group Agents affecting the nervous system More	15 mg/ml 1 ml №10	N07АА
Ipidacord Ipidacord 5 mg/ml 1 ml №10, №100 Solution for injections Active ingredient Ipidacrine hydrochloride Pharmacotherapeutic group Agents affecting the nervous system More	5 mg/ml 1 ml №10, №100	N07АА
Kineyron Kineyron 75 мг №21 Hard capsules Active ingredient Pharmacotherapeutic group Agents affecting the nervous system More	75 мг №21	N03A X16
Kineyron Kineyron 150 мг №21 Hard capsules Active ingredient Pharmacotherapeutic group Agents affecting the nervous system More	150 мг №21	N03A X16
Kineyron Kineyron 300 мг №21 Hard capsules Active ingredient Pharmacotherapeutic group Agents affecting the nervous system More	300 мг №21	N03A X16
Kineyron Kineyron 75 mg №56 Hard capsules Active ingredient Pharmacotherapeutic group Agents affecting the nervous system More	75 mg №56	N03A X16
Kineyron Kineyron 150 mg №56 Hard capsules Active ingredient Pharmacotherapeutic group Agents affecting the nervous system More	150 mg №56	N03A X16
Kineyron Kineyron 300 mg №56 Hard capsules Active ingredient Pharmacotherapeutic group Agents affecting the nervous system More	300 mg №56	N03A X16
Leknizine Leknizine 0,025 g № 10, № 50 Active ingredient Cinnarizine Pharmacotherapeutic group Agents affecting the nervous system More	0,025 g № 10, № 50	N07CA02
Lektil 200 Lektil 200 200 mg №50 Active ingredient Carbamazepine Pharmacotherapeutic group Agents affecting the nervous system More	200 mg №50	N03A F01
Lidocaine Lidocaine 20 mg/ml, 2 ml in ampoules № 10 Solution for injections Active ingredient Lidocaine hydrochloride Pharmacotherapeutic group Agents affecting the nervous system More	20 mg/ml, 2 ml in ampoules № 10	N01BB02
Lidocaine Lidocaine 10 mg/ml, 3,5 ml № 10 Solution for injections Active ingredient Lidocaine hydrochloride Pharmacotherapeutic group Agents affecting the nervous system More	10 mg/ml, 3,5 ml № 10	N01BВ02
Nalbuphine Nalbuphine 10 mg/ml 1 ml №10 Solution for injections Active ingredient Nalbuphine hydrochloride Pharmacotherapeutic group Agents affecting the nervous system More	10 mg/ml 1 ml №10	N02AF02
Nalbuphine Nalbuphine 10 mg/ml 2 ml №5 Solution for injections Active ingredient Nalbuphine hydrochloride Pharmacotherapeutic group Agents affecting the nervous system More	10 mg/ml 2 ml №5	N02AF02
Novocaine Novocaine 5 mg/ml, 5 ml № 10 Solution for injections Active ingredient Procaine hydrochloride Pharmacotherapeutic group Agents affecting the nervous system More	5 mg/ml, 5 ml № 10	N01BA02
Paracetamol Paracetamol 500 mg №10, №20, №50 Tablets Active ingredient Paracetamol Pharmacotherapeutic group Agents affecting the nervous system More	500 mg №10, №20, №50	N02B E01
Piracetam Piracetam 200 mg/mg, 5 ml № 10 Solution for injections Active ingredient Piracetam Pharmacotherapeutic group Agents affecting the nervous system More	200 mg/mg, 5 ml № 10	N06BX03
Tet 36.6 RAPID with acacia flavour Tet 36.6 RAPID with acacia flavour 23 g № 5, № 10 Powder for oral solution Active ingredient Paracetamol, phenylephrine hydrochloride, pheniramine maleate, ascorbic acid Pharmacotherapeutic group Agents affecting the nervous system More	23 g № 5, № 10	N02BЕ51
Tet 36.6 RAPID with lemon flavour Tet 36.6 RAPID with lemon flavour 23 g № 5, № 10 Powder for oral solution Active ingredient Paracetamol, phenylephrine hydrochloride, pheniramine maleate, ascorbic acid Pharmacotherapeutic group Agents affecting the nervous system More	23 g № 5, № 10	N02BЕ51
Tеt 36.6 MAXI with lemon flavour Tеt 36.6 MAXI with lemon flavour 23 g № 5, № 10 Powder for oral solution Active ingredient Paracetamol, phenylephrine hydrochloride, pheniramine maleate, ascorbic acid Pharmacotherapeutic group Agents affecting the nervous system More	23 g № 5, № 10	N02BЕ51
Tеt 36.6 MAXI with raspberry flavour Tеt 36.6 MAXI with raspberry flavour 23 g № 5, № 10 Powder for oral solution Active ingredient Paracetamol, phenylephrine hydrochloride, pheniramine maleate, ascorbic acid Pharmacotherapeutic group Agents affecting the nervous system More	23 g № 5, № 10	N02BE51
Tеt 36.6 with acacia flavour Tеt 36.6 with acacia flavour 13,1 g № 5, № 10 Powder for oral solution Active ingredient Paracetamol, pheniramine maleate, ascorbic acid Pharmacotherapeutic group Agents affecting the nervous system More	13,1 g № 5, № 10	N02BE51
Venocor Venocor 50 mg/ml, 5 ml № 5 Solution for injections Active ingredient Ethylmethylhydroxypyridine succinate Pharmacotherapeutic group Agents affecting the nervous system More	50 mg/ml, 5 ml № 5	N07XX
Venocor Venocor 50 mg/ml 2 ml № 10 Solution for injections Active ingredient Ethylmethylhydroxypyridine succinate Pharmacotherapeutic group Agents affecting the nervous system More	50 mg/ml 2 ml № 10	N07XX
Vinpocetin Vinpocetin 0,005 g № 30, № 50 Tablets Active ingredient Vinpocetine Pharmacotherapeutic group Agents affecting the nervous system More	0,005 g № 30, № 50	N06BX18

Anti-parasite agents, insecticides and repellents

Anti-parasite agents, insecticides and repellents

Name	Dosage form	ATC code
PerMin PerMin 50 g Solution for external administration Active ingredient Permethrin Pharmacotherapeutic group Anti-parasite agents, insecticides and repellents More	50 g	-
PerMin NEW PerMin NEW 50 ml Solution for external administration Active ingredient Permethrin Pharmacotherapeutic group Anti-parasite agents, insecticides and repellents More	50 ml	-

Agents affecting the respiratory system

Agents affecting the respiratory system

Name	Dosage form	ATC code
Alergolik Alergolik 5 mg № 10 Film-coated tablets Active ingredient Levocetirizine Pharmacotherapeutic group Agents affecting the respiratory system More	5 mg № 10	R06AE09
Alergolik Alergolik 5 mg/ml, 10 ml № 1 Oral drops Active ingredient Levocetirizine Pharmacotherapeutic group Agents affecting the respiratory system More	5 mg/ml, 10 ml № 1	R06AE09
Alergolik Alergolik 5 mg № 30 Film-coated tablets Active ingredient Levocetirizine Pharmacotherapeutic group Agents affecting the respiratory system More	5 mg № 30	R06AE09
Ambroxol Ambroxol 0,03 g № 20 Tablets Active ingredient Ambroxol hydrochloride Pharmacotherapeutic group Agents affecting the respiratory system More	0,03 g № 20	R05CB06
Desloratadine Desloratadine 0,5 mg/ml, 60 ml № 1 Syrup Active ingredient Desloratadine Pharmacotherapeutic group Agents affecting the respiratory system More	0,5 mg/ml, 60 ml № 1	R06AX27
Desloratadine Desloratadine 5 mg № 10, № 30 Film-coated tablets Active ingredient Desloratadine Pharmacotherapeutic group Agents affecting the respiratory system More	5 mg № 10, № 30	R06AX27
Ketotifen Ketotifen 0,001 g № 10 Tablets Active ingredient Ketotifen fumarate Pharmacotherapeutic group Agents affecting the respiratory system More	0,001 g № 10	R06AX17
Ketotifen Ketotifen 0,001 g № 30 Tablets Active ingredient Ketotifen fumarate Pharmacotherapeutic group Agents affecting the respiratory system More	0,001 g № 30	R06AX17
Loratadine Loratadine 0,01 g № 20 Tablets Active ingredient Loratadine Pharmacotherapeutic group Agents affecting the respiratory system More	0,01 g № 20	R06AX13
Loratadine Loratadine 0,01 g № 10 Tablets Active ingredient Loratadine Pharmacotherapeutic group Agents affecting the respiratory system More	0,01 g № 10	R06AX13
Lorolik Lorolik 50 ml Oral spray Active ingredient Hexetidine, choline salicylate, chlorobutanol hemihydrate Pharmacotherapeutic group Agents affecting the respiratory system More	50 ml	R02AA20
Lorolik Lorolik 125 ml Solution for oral cavity Active ingredient Hexetidine, choline salicylate, chlorobutanol hemihydrate Pharmacotherapeutic group Agents affecting the respiratory system More	125 ml	R02AA20
Mucolik Mucolik 2%, 125 ml Syrup Active ingredient Carbocisteine Pharmacotherapeutic group Agents affecting the respiratory system More	2%, 125 ml	R05CB03
Mucolik Mucolik 5%, 125 ml Syrup Active ingredient Carbocisteine Pharmacotherapeutic group Agents affecting the respiratory system More	5%, 125 ml	R05СВ03
Mucosol Mucosol 7,5 мг/мл 2 ml №10 Solution for infusions Active ingredient Ambroxol hydrochloride Pharmacotherapeutic group Agents affecting the respiratory system More	7,5 мг/мл 2 ml №10	R05C B06
Mucosol Mucosol 7,5 мг/мл 2 ml №5 Solution for infusions Active ingredient Ambroxol hydrochloride Pharmacotherapeutic group Agents affecting the respiratory system More	7,5 мг/мл 2 ml №5	R05CB06
Suprostilin Suprostilin 0,025 g № 10, № 20 Tablets Active ingredient Chloropyramine hydrochloride Pharmacotherapeutic group Agents affecting the respiratory system More	0,025 g № 10, № 20	R06AC03

Miscellaneous agents

Miscellaneous agents

Name	Dosage form	ATC code
Calcium folinate Calcium folinate 10 mg/ml 5 ml № 5 Solution for injections Active ingredient Folinic acid Pharmacotherapeutic group Miscellaneous agents More	10 mg/ml 5 ml № 5	V03AF03
Water for injections Water for injections 2 ml № 10 Solvent for parenteral administration Active ingredient Water for injections Pharmacotherapeutic group Miscellaneous agents More	2 ml № 10	V07AB
Water for injections Water for injections 5 ml № 10 Solvent for parenteral administration Active ingredient Water for injections Pharmacotherapeutic group Miscellaneous agents More	5 ml № 10	V07AB

HP.

Healthcare Products

HP.

Healthcare Products

Name	Dosage form	ATC code
AllSept AllSept 500 ml, 1000 ml, 5000 ml Solution for external administration Active ingredient Isopropyl alcohol, benzalkonium chloride, purified water Pharmacotherapeutic groupHealthcare Products More	500 ml, 1000 ml, 5000 ml
AllSept 75 AllSept 75 50 ml Solution for external administration Active ingredient Isopropyl alcohol, benzalkonium chloride, purified water Pharmacotherapeutic groupHealthcare Products More	50 ml
Bifolac Bifolac № 5, № 10 Vaginal suppositories Active ingredient Lactic and bifidumbacteria Pharmacotherapeutic groupHealthcare Products More	№ 5, № 10	-
Fitoprost Fitoprost № 5, № 10 Rectal suppositories Active ingredient Palmetto dry extract, pumpkin seed dry extract, nettle root dry extract Pharmacotherapeutic groupHealthcare Products More	№ 5, № 10	-
L-carnitine L-carnitine 100 ml Syrup Active ingredient L-carnitine Pharmacotherapeutic groupHealthcare Products More	100 ml	-
Lactovag Lactovag № 5, № 10 Vaginal suppositories Active ingredient Lactic bacteria Pharmacotherapeutic groupHealthcare Products More	№ 5, № 10	-
Lakarne Lakarne 10 ml, 100 ml Syrup Active ingredient L-carnitine Pharmacotherapeutic groupHealthcare Products More	10 ml, 100 ml	-
Oblepiol Oblepiol 1,4 g № 10 Suppositories Active ingredient Sea-buckthorn oil that contains total carotenoids in terms of betacarotene; and tea-seed oil Pharmacotherapeutic groupHealthcare Products More	1,4 g № 10
Saccharin-T Saccharin-T 50 tablets, 0,1 g Tablets Active ingredient Pharmacotherapeutic groupHealthcare Products More	50 tablets, 0,1 g	-
SanteFem SanteFem № 10, № 14 Vaginal suppositories Active ingredient Boric acid, Vitamin E, Tea tree oil, Sodium hyaluronate Pharmacotherapeutic groupHealthcare Products More	№ 10, № 14	-
Tablets Pechaevskie Tablets Pechaevskie with raspberry taste Tablets Active ingredient Pharmacotherapeutic groupHealthcare Products More	with raspberry taste	-
Tablets Pechaevskie Tablets Pechaevskie with mint taste Tablets Active ingredient Pharmacotherapeutic groupHealthcare Products More	with mint taste	-
Tablets Pechaevskie Tablets Pechaevskie with forest berry taste Tablets Active ingredient Pharmacotherapeutic groupHealthcare Products More	with forest berry taste	-
Tablets Pechaevskie Tablets Pechaevskie with tangerine taste Tablets Active ingredient Pharmacotherapeutic groupHealthcare Products More	with tangerine taste	-
Tablets Pechaevskie Tablets Pechaevskie with no-sugar contains Tablets Active ingredient Pharmacotherapeutic groupHealthcare Products More	with no-sugar contains	-